Erik Fj de Vries

26PUBLICATIONS
46CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Toxicology (incl. clinical toxicology)Medical infection agents (incl. prions)Medical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|May 11, 2026
Head-to-head comparison of nuclear imaging approaches to quantify tumor CD8+ T-cell infiltration.

|Sep 08, 2025
Dopamine D2/3R availability after discontinuation of antipsychotic treatment: a [11C]raclopride PET study in remitted first-episode psychosis patients.

Franciska de Beer, Erik de Vries, Ben Wijnen

|Jul 12, 2025
DSC Perfusion MRI Artefact Reduction Strategies: A Short Overview for Clinicians and Scientific Applications.

Chris W J van der Weijden, Ingomar W Gutmann, Joost F Somsen

|Jul 12, 2025
The Future of PET Imaging in Multiple Sclerosis: Characterisation of Individual White Matter Lesions.

Chris W J van der Weijden, Jan F Meilof, Anouk van der Hoorn

|Sep 14, 2024
Unsupervised Pattern Analysis to Differentiate Multiple Sclerosis Phenotypes Using Principal Component Analysis on Various MRI Sequences.

Chris W J van der Weijden, Milena S Pitombeira, Débora E Peretti

|Feb 24, 2024
Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.

Jorianne Boers, Bertha Eisses, Mieke C Zwager

Pageof 5

Frequent Collaborators

5 joint publications

Andor Wjm Glaudemans

4 joint publications

Chris Wj van der Weijden

3 joint publications

Jasper J L van Geel

2 joint publications

Willemien C Menke-van der Houven van Oordt